Acurx Pharmaceuticals (ACXP) Stock Chart & Stock Price History $0.42 +0.00 (+0.39%) As of 12:35 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Acurx Pharmaceuticals Stock Price Performance 5 Day Performance+2.57%1 Month Performance+15.60%3 Month Performance-43.20%6 Month Performance-77.69%Year-To-Date Performance-49.02%1 Year Performance-80.42% Receive ACXP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Acurx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address ACXP Stock Chart for Friday, May, 2, 2025 ACXP Chart by TradingView Acurx Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/01/2025$0.43$0.41-3.86%$0.43$0.4187,782 shs$9.26 million04/30/2025$0.42$0.43+2.38%$0.44$0.42199,649 shs$9.63 million04/29/2025$0.42$0.42+0.24%$0.43$0.41175,812 shs$9.41 million04/28/2025$0.40$0.42+3.56%$0.43$0.4054,256 shs$9.39 million04/25/2025$0.40$0.40+0.72%$0.41$0.4082,898 shs$9.06 million04/24/2025$0.39$0.40+3.80%$0.40$0.39116,270 shs$9.00 million04/23/2025$0.38$0.39+2.73%$0.40$0.3882,055 shs$8.67 million04/22/2025$0.37$0.38+2.09%$0.38$0.3753,502 shs$8.44 million04/21/2025$0.37$0.37-0.27%$0.38$0.36119,767 shs$8.27 million04/18/2025$0.37$0.37$0.40$0.36148,025 shs$8.29 million Get the Latest News and Ratings for ACXP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Acurx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 04/17/2025$0.39$0.37-3.92%$0.40$0.36148,025 shs$8.29 million04/16/2025$0.38$0.39+1.34%$0.40$0.3867,868 shs$8.63 million04/15/2025$0.38$0.38-0.63%$0.39$0.3883,113 shs$8.51 million04/14/2025$0.35$0.38+7.93%$0.39$0.36147,676 shs$8.57 million04/11/2025$0.34$0.35+5.60%$0.36$0.34101,940 shs$7.94 million04/10/2025$0.33$0.34+2.04%$0.34$0.32121,901 shs$7.52 million04/09/2025$0.31$0.33+7.80%$0.34$0.30137,958 shs$7.25 million04/09/2025$0.31$0.33+7.80%$0.34$0.30137,958 shs$7.25 million04/08/2025$0.33$0.31-7.07%$0.34$0.31117,606 shs$6.72 million04/08/2025$0.33$0.31-7.07%$0.34$0.31117,606 shs$6.72 million04/07/2025$0.32$0.33+2.56%$0.33$0.30238,440 shs$7.24 million04/04/2025$0.33$0.32-3.03%$0.34$0.32214,067 shs$7.05 million04/03/2025$0.36$0.33-8.08%$0.36$0.32194,100 shs$7.27 million04/02/2025$0.38$0.36-5.35%$0.38$0.35234,767 shs$7.91 million04/01/2025$0.39$0.38-2.74%$0.40$0.38151,358 shs$8.36 million Related Companies X4 Pharmaceuticals Stock Price Chart Scilex Stock Price Chart OS Therapies Stock Price Chart NRx Pharmaceuticals Stock Price Chart Surrozen Stock Price Chart Alterity Therapeutics Stock Price Chart Cadrenal Therapeutics Stock Price Chart Pluri Stock Price Chart Marinus Pharmaceuticals Stock Price Chart Kezar Life Sciences Stock Price Chart Receive ACXP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Acurx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ACXP) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredElon Musk is all in on these robots …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acurx Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Acurx Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ACXP Stock Free ACXP Stock Alerts